In medicine the results of clinical trials are used to make informed treatments about which treatments work best. But there is a problem: the results of clinical trials are being routinely and legally withheld from doctors, researchers, and patients. This is a problem for industry sponsored trials, and for trials funded by governments and charities.
The AllTrials Transparency Index ranks all the world’s major drug companies, and a selection of smaller firms, by the commitments they make to clinical trials transparency.
All companies were sent the full set of data extracted for their company’s policy, and invited to respond setting out any disagreement they had on any element, by making reference to the text of their publicly accessible policy. Emails were sent to the CEO, Medical Director, and other email accounts for individuals in relevant roles who had previously responded to us on related queries regarding transparency.
All responses were read, any disagreements were extracted and reviewed by at least two members of the audit team, and changes were made where appropriate. In total, 7 out of 1806 scored policy elements were revised in light of feedback from companies. If any company has any concerns about our summary of their public policy after publication of the audit then we are also happy to review additional feedback.
The AllTrials Transparency Index website includes the AllTrials assessment of every company’s policy and the data can also be downloaded as a single spreadsheet here.
The AllTrials Transparency Index website also includes an archive of every company’s public policy as it stood at the time of the 2017 audit.